Sign Up to like & get
recommendations!
1
Published in 2021 at "World Psychiatry"
DOI: 10.1002/wps.20906
Abstract: Major depression is often a relapsing disorder. It is therefore important to start its treatment with therapies that maximize the chance of not only getting the patients well but also keeping them well. We examined…
read more here.
Keywords:
phase;
treatment;
sustained response;
maintenance phase ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad108
Abstract: Generalized pustular psoriasis (GPP) is a rare skin disease characterized by generalized sterile pustules with or without severe systemic symptoms. Here we share our experience with Spesolimab in 5 Chinese GPP flare patients.
read more here.
Keywords:
spesolimab;
sustained response;
generalized pustular;
pustular psoriasis ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "British journal of haematology"
DOI: 10.1111/bjh.18842
Abstract: Eltrombopag (ELT) is effective and safe in adult persistent/chronic immune thrombocytopenia (p/cITP); a proportion could achieve a sustained response off treatment (SRoT); however, data on children are lacking. We attempted to analyse SRoT of ELT…
read more here.
Keywords:
immune thrombocytopenia;
sustained response;
persistent chronic;
treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-137398
Abstract: Corticosteriods (CSs) remain the standard of care for immune thrombocytopenia (ITP); however, many patients relapse after initial treatment, and long-term CS use is associated with considerable toxicity and tolerability issues (Provan et al. Blood 2010).…
read more here.
Keywords:
treatment;
sustained response;
speakers bureau;
honoraria speakers ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Haematologica"
DOI: 10.3324/haematol.2016.160408
Abstract: Over the past decade, the survival of patients with multiple myeloma (MM) has dramatically improved. This remarkable change is largely due to an increase in the anti-myeloma armamentarium, including next generation proteasome inhibitors (carfilzomib, ixazomib),…
read more here.
Keywords:
sustained response;
venetoclax therapy;
myeloma;
response venetoclax ... See more keywords